Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Más filtros

Medicinas Complementárias
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
2.
Curr Opin Allergy Clin Immunol ; 19(4): 334-340, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31145193

RESUMEN

PURPOSE OF REVIEW: The purpose was to highlight recent findings especially concerning new and old allergens, trends, diagnosis and causes of contact allergy. RECENT FINDINGS: Nickel is still the most frequent cause of contact allergy in women and piercings remain an important risk factor. Countries with a long history of regulation of contact allergens have the lowest level of contact allergy to nickel and chromium in Europe. Among the most frequent causes of fragrance contact allergy is terpenes, which are oxidized such as limonene, linalool and in some countries: geraniol. Methylisothiazolinone is still causing considerable problems due to hidden exposures. Acrylates are emerging allergens and 2-hydroxyethyl methacrylate has been included in the 2019 update of the baseline series, as many new cases are seen due to long-lasting nail polish based on acrylates and glue (isobornyl acrylate) in insulin pumps. More than 10 new allergens have been described, which need to be considered in diagnosing contact allergy. SUMMARY: Allergic contact dermatitis is a frequent problem, it also constitutes a challenge to diagnose due to many potential contact allergens. The main culprit allergens remain the same, new significant causes are found especially within acrylates.


Asunto(s)
Dermatitis Alérgica por Contacto/inmunología , Diabetes Mellitus/tratamiento farmacológico , Insulina/uso terapéutico , Adhesivos/efectos adversos , Alérgenos/efectos adversos , Alérgenos/inmunología , Dermatitis Alérgica por Contacto/epidemiología , Europa (Continente) , Femenino , Humanos , Bombas de Infusión Implantables , Masculino , Níquel/inmunología , Odorantes , Riesgo , Terpenos/inmunología , Tiazoles/inmunología
4.
J Immunotoxicol ; 13(3): 364-74, 2016 05.
Artículo en Inglés | MEDLINE | ID: mdl-26634391

RESUMEN

Multiple sclerosis (MS) is a central nervous system disorder mainly characterized by inflammation, demyelination and axonal injury. Anti-inflammatory agents can be used to ameliorate the disease process. Hypericum perforatum L or St. John's wort is widely used as an anti-depressant and anti-inflammatory remedy in traditional and herbal medicine. Based on St. John's wort properties, the therapeutic potentials of an H. perforatum extract (HPE) and a single component, hyperforin were evaluated for effectiveness against MOG35-55-induced experimental autoimmune encephalomyelitis (EAE), an animal model for human multiple sclerosis. Female C57BL/6 mice were immunized with specific antigen MOG35-55 and then administered different doses of hyperforin or HPE post-immunization. Clinical symptoms/other relevant parameters were assessed daily. Histological analysis of the spinal cord was performed. T-cell proliferative activity was also evaluated using a BrdU assay. The effect of hyperforin on regulatory T-cells (Treg cells) was assessed using flow cytometry. The results indicate hyperforin and HPE reduced the incidence and severity of EAE, an outcome that closely correlated with an inhibition of pathological features (leukocyte infiltration and demyelination) and antigen-specific T-cell proliferation. The study also showed that hyperforin caused increased Treg cell levels in the spleen. These results indicated that hyperforin and HPE could attenuate EAE autoimmune responses by inhibiting immune cell infiltration and expansion of Treg cell and could eventually be considered as a potential candidate for use in the treatment of MS.


Asunto(s)
Encefalomielitis Autoinmune Experimental/terapia , Hypericum/inmunología , Esclerosis Múltiple/terapia , Floroglucinol/análogos & derivados , Fitoterapia , Bazo/inmunología , Linfocitos T Reguladores/inmunología , Terpenos/inmunología , Animales , Proliferación Celular , Modelos Animales de Enfermedad , Encefalomielitis Autoinmune Experimental/inmunología , Femenino , Humanos , Ratones , Ratones Endogámicos C57BL , Esclerosis Múltiple/inmunología , Glicoproteína Mielina-Oligodendrócito/inmunología , Fragmentos de Péptidos/inmunología , Floroglucinol/inmunología , Floroglucinol/uso terapéutico , Terpenos/uso terapéutico
5.
J Immunol ; 194(6): 2539-50, 2015 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-25672758

RESUMEN

Rheumatoid arthritis (RA) is associated with amino acid variants in multiple MHC molecules. The association to MHC class II (MHC-II) has been studied in several animal models of RA. In most cases these models depend on T cells restricted to a single immunodominant peptide of the immunizing Ag, which does not resemble the autoreactive T cells in RA. An exception is pristane-induced arthritis (PIA) in the rat where polyclonal T cells induce chronic arthritis after being primed against endogenous Ags. In this study, we used a mixed genetic and functional approach to show that RT1-Ba and RT1-Bb (RT1-B locus), the rat orthologs of HLA-DQA and HLA-DQB, determine the onset and severity of PIA. We isolated a 0.2-Mb interval within the MHC-II locus of three MHC-congenic strains, of which two were protected from severe PIA. Comparison of sequence and expression variation, as well as in vivo blocking of RT1-B and RT1-D (HLA-DR), showed that arthritis in these strains is regulated by coding polymorphisms in the RT1-B genes. Motif prediction based on MHC-II eluted peptides and structural homology modeling suggested that variants in the RT1-B P1 pocket, which likely affect the editing capacity by RT1-DM, are important for the development of PIA.


Asunto(s)
Artritis Experimental/genética , Artritis Reumatoide/genética , Predisposición Genética a la Enfermedad , Antígenos de Histocompatibilidad/genética , Secuencia de Aminoácidos , Aminoácidos/genética , Animales , Anticuerpos Bloqueadores/inmunología , Anticuerpos Bloqueadores/farmacología , Artritis Experimental/inmunología , Artritis Reumatoide/inmunología , Sitios de Unión/genética , Peso Corporal/efectos de los fármacos , Peso Corporal/inmunología , Modelos Animales de Enfermedad , Genotipo , Haplotipos/inmunología , Antígenos de Histocompatibilidad/química , Antígenos de Histocompatibilidad/inmunología , Humanos , Modelos Moleculares , Datos de Secuencia Molecular , Polimorfismo Genético/inmunología , Estructura Terciaria de Proteína , Ratas , Índice de Severidad de la Enfermedad , Terpenos/inmunología
7.
Dev Comp Immunol ; 41(4): 675-82, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23948148

RESUMEN

Fish farming crops are constantly exposed to infectious diseases due to intensive production conditions under which microorganisms develop and spread easily, resulting in severe economic losses. The massive use of antibiotics to control these diseases has lead to the accumulation of residues and the development of drug resistance. Consequently, it is urgent to develop new pharmacological tools to stimulate protective immune responses in salmonids to combat infectious diseases. We evaluated the immunostimulant activity of terpenoid derivatives isolated from species of the Heliotropium genus, which had previously shown antiviral activity in salmon. The immunomodulatory effects of the 3 H-spiro [1-benzofuran-2,1'-ciclohexane] derivative called filifolinone, were studied in vitro using the SHK-1 cell line derived from leucocytes of salmon head kidney and in vivo in Atlantic salmon. For the evaluation, we studied the effect of this compound in the expression of various cytokines. The results showed that Filifolinone increases the levels of expression of pro-inflammatory and anti-inflammatory cytokines. This suggests that Filifolinone is a potential alternative immunomodulator for veterinary purposes.


Asunto(s)
Citocinas/biosíntesis , Enfermedades de los Peces/tratamiento farmacológico , Enfermedades de los Peces/inmunología , Factores Inmunológicos/farmacología , Extractos Vegetales/farmacología , Salmón/inmunología , Terpenos/farmacología , Animales , Línea Celular , Citocinas/inmunología , Heliotropium/inmunología , Factores Inmunológicos/inmunología , Extractos Vegetales/inmunología , Terpenos/inmunología
8.
Eur J Pharm Sci ; 47(1): 152-61, 2012 Aug 30.
Artículo en Inglés | MEDLINE | ID: mdl-22659375

RESUMEN

Two triterpenoids ursolic acid (1) and lupeol (2) isolated and characterized from Eucalyptus tereticornis and Gentiana kurroo were subjected to in silico QSAR modeling and docking studies and later the predicted results were confirmed through in vivo experiments. QSAR modeling results showed that both the triterpenoids possess immunomodulatory and anti-inflammatory activity comparable to boswellic and cichoric acids, but were less active than levamisol. Docking results suggested that both the triterpenoids (1 and 2) showed immune modulatory and anti-inflammatory activity due to high binding affinity to human receptors viz., NF-kappaB p52 (-50.549 kcal/mol), tumor necrosis factor (TNF-alpha) (-47.632 kcal/mol), nuclear factor NF-Kappa-B P50 (-16.798 kcal/mol) and cyclooxygenase-2 (-55.244 kcal/mol). Further both the triterpenoids (1 and 2) were subjected to in vivo immunomodulatory activity in female Swiss albino mice. The experimental mice were divided into nine groups, each comprised of six mice. These received oral treatment for a period of 28 days. The triterpenoids (1 and 2) showed significant increased in humoral immune function, but no significant changes were observed in cell mediated immune response and hematological parameters. The in silico and in vivo experimental data suggested that both the triterpenoids 1 and 2 may be considered as potential immunomodulatory drug-like molecules.


Asunto(s)
Eucalyptus/química , Gentiana/química , Factores Inmunológicos/química , Factores Inmunológicos/farmacología , Terpenos/química , Terpenos/farmacología , Animales , Antiinflamatorios/química , Antiinflamatorios/inmunología , Antiinflamatorios/aislamiento & purificación , Antiinflamatorios/farmacología , Ciclooxigenasa 2/inmunología , Femenino , Humanos , Factores Inmunológicos/inmunología , Factores Inmunológicos/aislamiento & purificación , Ratones , Modelos Moleculares , FN-kappa B/inmunología , Subunidad p52 de NF-kappa B/inmunología , Triterpenos Pentacíclicos/química , Triterpenos Pentacíclicos/inmunología , Triterpenos Pentacíclicos/aislamiento & purificación , Triterpenos Pentacíclicos/farmacología , Extractos Vegetales/inmunología , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Hojas de la Planta/química , Relación Estructura-Actividad Cuantitativa , Conejos , Terpenos/inmunología , Terpenos/aislamiento & purificación , Triterpenos/química , Triterpenos/inmunología , Triterpenos/aislamiento & purificación , Triterpenos/farmacología , Factor de Necrosis Tumoral alfa/inmunología , Ácido Ursólico
9.
Rev. fitoter ; 9(2): 133-145, dic. 2009. tab, ilus
Artículo en Español | IBECS | ID: ibc-77477

RESUMEN

El género Sideritis L. abarca un conjunto de especies vegetales pertenecientes a la familia Lamiáceas ampliamente distribuidas por la región mediterránea, tanto europea y africana como asiática. Tradicionalmente se utilizan por sus propiedades antiinflamatorias, digestivas y antimicrobianas. Desde el punto de vista botánico, este género presenta dificultades en su clasificación debido a la tendencia a la hibridación entre sus numerosas especies. La parte utilizada en medicina tradicional es la sumidad florida, que contiene como principios activos más destacados flavonoides, terpenos y aceite esencial, siendo todos ellos responsables de sus actividades farmacológicas. Estudios recientes demuestran estas actividades y avalan tanto su uso tradicional como posibles nuevas aplicaciones terapéuticas (AU)


The genus Sideritis L., comprises several plant specie belonging to the Lamiaceae family that are widely distributed in the European, African and Asiatic Mediterranean region. Several species are used in folk medicine because of its anti-inflammatory, anti-ulcer and antimicrobial properties. From the botanical point of view, the genus Sideritis has been difficult to classify because of the strong tendency of a number of species to hybridaze. The part used in traditional medicine are the flowering tops. They contain flavonoids, terpenes and essential oil that are responsible of the pharmacological activities. Recent studies prove these activities that support both their traditional uses and their potential new therapeutic applications (AU)


Asunto(s)
Sideritis , Sideritis/inmunología , Lamiaceae , Lamiaceae/inmunología , Fitoterapia/métodos , Terpenos/administración & dosificación , Terpenos/antagonistas & inhibidores , Terpenos/farmacología , Plantas Medicinales/inmunología , Terpenos/inmunología , Terpenos/uso terapéutico
10.
Contact Dermatitis ; 53(5): 285-91, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16283907

RESUMEN

The aim of this study was to assess the strength of any association between sensitization to 'new' fragrance compounds and sensitization to Compositae, fragrance mix, Myroxylon pereirae resin and colophonium, respectively. Consecutive eczema patients were tested with a series of essential oils and selected fragrance compounds and another series of oxidized terpenes in connection with European multicentre fragrance projects. Contact allergy to either series was frequently detected, in 5% of 318 and 4.6% of 262 persons tested, and both had a statistically significant association with Compositae, colophonium and fragrance mix sensitization. The individual results indicated that simultaneously occurring positive reactions to essential oils, colophonium and Compositae were based on cross-reactivity rather than concomitant sensitization. Thus, all patients with positive reaction to the rare fragrance sensitizer beta-caryophyllene had positive colophonium reactions, and cross-reactivity between essential oils and Compositae was related to the Compositae plant extracts of the Compositae mix and not the pure sesquiterpene lactones of the standard series. The implication is that Compositae mix and colophonium may be markers of fragrance allergy, which is important to know when assessing the relevance of positive reactions to Compositae plant extracts and colophonium.


Asunto(s)
Asteraceae/inmunología , Reacciones Cruzadas , Dermatitis Alérgica por Contacto/etiología , Myroxylon/inmunología , Perfumes/efectos adversos , Extractos Vegetales/efectos adversos , Adulto , Anciano , Asteraceae/efectos adversos , Biomarcadores , Dermatitis Alérgica por Contacto/inmunología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Myroxylon/efectos adversos , Aceites Volátiles/efectos adversos , Sesquiterpenos Policíclicos , Resinas de Plantas/efectos adversos , Estudios Retrospectivos , Sesquiterpenos/efectos adversos , Sesquiterpenos/inmunología , Pruebas Cutáneas , Terpenos/efectos adversos , Terpenos/inmunología
11.
Vet Ther ; 3(3): 347-53, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12447843

RESUMEN

Holstein steer calves received a single injection of Miglyol (Sasol Chemical Industries, Ltd.) subcutaneously as a placebo, dihydroheptaprenol (DHP) (4 mg/kg) emulsified with lecithin subcutaneously, DHP in solution in Miglyol (4 mg/kg) subcutaneously, or DHP in solution in Miglyol (4 mg/kg) intranasally. The DHP emulsified in lecithin emulsion administered subcutaneously caused a substantial increase in body temperature, total leukocyte count, total neutrophil count, neutrophil cytochrome-c reduction, and neutrophil iodination 24 hours after administration and, for some of the parameters, at 48 hours. The DHP formulation in Miglyol did not have any of these effects when administered subcutaneously or intranasally. The carrier and formulation of DHP apparently have major effects on the biologic activity of DHP.


Asunto(s)
Bovinos , Terpenos/administración & dosificación , Terpenos/inmunología , Adyuvantes Inmunológicos/administración & dosificación , Administración Intranasal , Animales , Temperatura Corporal/efectos de los fármacos , Química Farmacéutica , Grupo Citocromo c/metabolismo , Emulsiones/administración & dosificación , Inyecciones Subcutáneas , Recuento de Leucocitos , Masculino , Activación Neutrófila/efectos de los fármacos , Fosfatidilcolinas , Soluciones/administración & dosificación , Terpenos/farmacología , Factores de Tiempo
12.
Br J Dermatol ; 146(4): 649-56, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11966698

RESUMEN

BACKGROUND: For patients with allergic contact dermatitis, the main therapy is anti-inflammatory steroids, a non-specific and symptomatic treatment. In contact allergy, the antigen formation is considered to be the binding of a chemical (hapten) to a biological macromolecule, e.g. a protein. Limonene-2-hydroperoxide (Lim-OOH) is a hapten with a known allergenic effect. It is likely to bind to proteins in the skin via a radical mechanism. It might be possible to inhibit the allergic reaction by epidermal application of substances that can trap free radicals, e.g. antioxidants such as ascorbic acid or alpha-tocopherol, prior to the application of the hapten. OBJECTIVES: To study the influence of antioxidants on the allergenic effect of Lim-OOH in sensitization experiments on guinea pigs. METHODS: Pretreatment with the antioxidants was performed before induction to study the effect on sensitization as well as before challenge testing to study the effect on elicitation. RESULTS: A reduction in the response rate was found both at sensitization and at elicitation. The antioxidants had no effect on cobalt allergy or on the allergenic effect of haptens that form antigens via nucleophilic-electrophilic reactions. No reduction of the effect was seen for irritants. CONCLUSIONS: The protective effect of antioxidants in elicitation could be of practical therapeutic value, as it indicates a possibility for the treatment of patients who have become sensitized to haptens that form full antigens via a radical mechanism.


Asunto(s)
Antioxidantes/uso terapéutico , Dermatitis Alérgica por Contacto/prevención & control , Alérgenos/inmunología , Animales , Cobalto/inmunología , Ciclohexenos , Dermatitis Alérgica por Contacto/etiología , Dermatitis Alérgica por Contacto/inmunología , Femenino , Radicales Libres/inmunología , Cobayas , Haptenos/inmunología , Limoneno , Nitrilos/inmunología , Peróxidos/inmunología , Terpenos/inmunología
13.
Arthritis Rheum ; 44(11): 2697-702, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11710726

RESUMEN

OBJECTIVE: Oncostatin M (OSM) is a member of the interleukin-6 cytokine family, with well-documented effects on cell growth and differentiation. OSM also has proinflammatory and cartilage degradative properties. The aim of this study was to investigate the significance of OSM in arthritis pathology using a neutralizing antibody in arthritis models. METHODS: Collagen-induced arthritis (CIA) was established in male DBA/1 mice. Reverse transcriptase-polymerase chain reaction was used to detect OSM messenger RNA (mRNA) message levels in arthritic joints. Neutralizing anti-OSM antibody or control immunoglobulin was administered on days 1 and 3 after disease onset. Animals were assessed for clinical arthritis for 2 weeks, followed by a histologic analysis of paws. Pristane-induced arthritis (PIA) was produced in male CBA mice dosed with anti-OSM or control immunoglobulin immediately before disease onset. Mice with PIA were assessed for clinical arthritis over a period of 100 days. RESULTS: Levels of mRNA for OSM, but not GAPDH, were elevated in arthritic joints of mice with CIA compared with those of normal controls. Mice with CIA treated with anti-OSM antibody showed significant amelioration of both the clinical severity (P < 0.01) and the number of affected paws (P < 0.01) compared with control animals. Histologic analysis confirmed these clinical findings, revealing a marked reduction in cellular infiltration of synovium and cartilage damage. In the PIA model, the incidence of arthritis was 65% in the control group compared with 0% in the anti-OSM-treated animals. CONCLUSION: These results demonstrate a key role for endogenously produced OSM as a potent mediator of joint pathology, and suggest that OSM might be a potentially important, novel therapeutic target for treatment of established rheumatoid arthritis.


Asunto(s)
Anticuerpos/uso terapéutico , Artritis Experimental/tratamiento farmacológico , Proteínas Bacterianas , Péptidos/metabolismo , Animales , Artritis Experimental/inducido químicamente , Artritis Experimental/patología , Chaperonina 60 , Chaperoninas/farmacología , Colágeno/inmunología , Colágeno/farmacología , Cartilla de ADN/química , Modelos Animales de Enfermedad , Edema/tratamiento farmacológico , Gliceraldehído-3-Fosfato Deshidrogenasas/genética , Gliceraldehído-3-Fosfato Deshidrogenasas/inmunología , Gliceraldehído-3-Fosfato Deshidrogenasas/metabolismo , Inmunoglobulina G/administración & dosificación , Articulaciones/química , Articulaciones/efectos de los fármacos , Articulaciones/metabolismo , Articulaciones/patología , Masculino , Ratones , Ratones Endogámicos CBA , Ratones Endogámicos DBA , Oncostatina M , Péptidos/genética , Péptidos/inmunología , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Terpenos/inmunología , Terpenos/farmacología
14.
Clin Immunol ; 90(1): 119-27, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9884360

RESUMEN

To assess the efficiency of nasally administered cartilage-specific collagens as vaccination against development of arthritis and to ameliorate already established chronic arthritis, experimental models which develop chronic arthritis, pristane-induced arthritis (PIA), and homologous collagen-induced arthritis (CIA) in the rat were selected. Cartilage-specific collagens type IX (CIX) and type II (CII) were used for vaccination intranasally. A single dose of 250 microg CII instilled intranasally in rats with established PIA ameliorated the disease. For the prevention of disease, the same dose given before immunization was found to be most effective. Most importantly, the disease was more severe if this dose was given three times. For treatment of PIA, CIX was found to be more effective than CII, whereas for treatment of CIA only CII was effective. The amelioration of CIA was associated with a marked suppression of delayed type hypersensitivity and the flare reaction to CII and lower levels of IgG2b anti-CII antibodies in serum, i.e., with suppression of the TH1 rather than the TH2 response to CII. These findings, that cartilage proteins, if given intranasally, can both prevent and ameliorate established chronic arthritis in rats, are of significant importance for possible use in rheumatoid arthritis. The identification of two different cartilage-specific proteins (CII and CIX) effective against a disease induced with a well-defined nonimmunogenic adjuvant such as pristane will be of value for enhancing the effectiveness of the treatment.


Asunto(s)
Artritis Experimental/tratamiento farmacológico , Colágeno/administración & dosificación , Inmunosupresores/toxicidad , Terpenos/toxicidad , Administración Intranasal , Animales , Artritis Experimental/inmunología , Artritis Experimental/prevención & control , Colágeno/inmunología , Colágeno/toxicidad , Modelos Animales de Enfermedad , Inmunosupresores/inmunología , Ratas , Ratas Endogámicas Lew , Sensibilidad y Especificidad , Terpenos/inmunología , Células TH1/efectos de los fármacos , Células TH1/inmunología , Vacunación
15.
Clin Exp Immunol ; 103(1): 83-8, 1996 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8565293

RESUMEN

Previous work has indicated that autoimmunity to the mammalian 60-kD heat shock protein (hsp60) may be necessary for the development of pristane-induced arthritis (PIA), a murine model of rheumatoid arthritis. To characterize the expression of hsp60 in murine joints, immunoblots of joint extracts and frozen histological sections prepared from normal or arthritic mice were probed with the hsp60-specific MoAb 4B989. Hsp60 could be detected in the joints of mice with PIA by both techniques, and was seen to be localized within the inflamed pannus using immunhistochemistry. Immunoblotting revealed that lower concentrations of hsp60 are also present in normal mouse joints, and that the level of expression increases with age, in parallel with greater susceptibility to PIA. In other studies, it was demonstrated that the titres of serum IgG antibodies reactive with the related mycobacterial hsp65, and the in vitro responsiveness of splenic T cells to hsp65, are both elevated in older mice. It is considered that the results are consistent with the hypothesis that PIA develops following environmental priming with mycobacterial hsp65, and the targeting of cross-reactive T cells to self-hsp60 in the joints.


Asunto(s)
Artritis/metabolismo , Chaperonina 60/biosíntesis , Inmunosupresores/farmacología , Articulación de la Rodilla/metabolismo , Terpenos/inmunología , Factores de Edad , Animales , Artritis/etiología , Artritis/inmunología , Chaperonina 60/análisis , Electroforesis en Gel de Poliacrilamida , Femenino , Immunoblotting , Inmunohistoquímica , Articulación de la Rodilla/inmunología , Ratones , Ratones Endogámicos CBA
16.
Contact Dermatitis ; 29(4): 175-9, 1993 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8281778

RESUMEN

The sensitizing capacity of Centella asiatica (raw extract) and its triterpenic constituents asiaticoside, asiatic acid and madecassic acid has been studied in guinea pigs. The extract itself as well as the 3 acids were found to be very weak sensitizers. Centella asiatica extract is used effectively in the treatment of keloids, leg ulcers, phlebitis, slow-healing wounds, leprosy, surgical lesions, striae distensae and cellulitis. Although applied frequently to damaged skin, the risk of acquiring contact sensitivity to this plant or its constituents is low.


Asunto(s)
Desensibilización Inmunológica , Extractos Vegetales/uso terapéutico , Plantas Medicinales , Triterpenos/uso terapéutico , Adulto , Animales , Dermatitis Alérgica por Contacto/inmunología , Femenino , Cobayas , Humanos , Pruebas Intradérmicas , Pruebas del Parche , Triterpenos Pentacíclicos , Extractos Vegetales/inmunología , Terpenos/inmunología , Terpenos/uso terapéutico , Triterpenos/inmunología
17.
Vaccine ; 8(4): 376-80, 1990 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1697723

RESUMEN

The effect of a chemically synthesized polyprenol derivative, dihydroheptaprenol (DHP), on the non-specific resistance of mice to Sendai virus infection was investigated. The mice that received 200 micrograms of DHP intranasally twice, at 3 days and 1 day before the infection, showed a significant protection against Sendai virus infection. Treatment of mice twice even with as much as 2000 micrograms of DHP through the subcutaneous route, however, had no protective effect against infection. Excess interferon and tumour necrosis factor production in intranasally DHP-treated mice was seen 1 day after the infection when compared with Sendai virus alone controls or with DHP alone controls. Variance analysis of these findings indicates a prophylactic activity of DHP in pulmonary viral infections.


Asunto(s)
Infecciones por Paramyxoviridae/prevención & control , Terpenos/uso terapéutico , Administración Intranasal , Animales , Relación Dosis-Respuesta a Droga , Femenino , Inmunidad Innata/efectos de los fármacos , Interferones/biosíntesis , Ratones , Ratones Endogámicos , Virus de la Parainfluenza 1 Humana , Infecciones por Paramyxoviridae/inmunología , Infecciones por Paramyxoviridae/metabolismo , Infecciones por Pseudomonas/tratamiento farmacológico , Infecciones por Pseudomonas/inmunología , Infecciones por Pseudomonas/metabolismo , Terpenos/administración & dosificación , Terpenos/inmunología , Factor de Necrosis Tumoral alfa/biosíntesis
18.
J Immunol Methods ; 99(1): 21-3, 1987 May 04.
Artículo en Inglés | MEDLINE | ID: mdl-3571991

RESUMEN

A variety of agents were compared to pristane for priming mice prior to ascitic fluid production. Incomplete Freund's adjuvant was found to be as good as or better than pristane for priming before hybridoma cell inoculation. Complete adjuvant was also useful while priming with proteose-peptone; thioglycollate, corn oil or mineral oil elicited only minimum amounts of ascitic fluid after hybridoma injection.


Asunto(s)
Anticuerpos Monoclonales/biosíntesis , Líquido Ascítico/análisis , Terpenos/farmacología , Adyuvantes Inmunológicos/inmunología , Animales , Formación de Anticuerpos/efectos de los fármacos , Líquido Ascítico/metabolismo , Adyuvante de Freund/administración & dosificación , Hibridomas/efectos de los fármacos , Hibridomas/metabolismo , Ratones , Ratones Endogámicos BALB C , Terpenos/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA